Astellas Opens Brazilian Sales Affiliate, Completing Network In BRIC Countries
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Astellas Pharma has opened its first Brazilian beachhead, completing the expansion of its distribution network in the BRIC countries of Brazil, Russia, India and China, a company spokeswoman said July 22. Other Japanese pharmas, including Takeda, are gearing up to follow its lead
You may also be interested in...
Japanese Pharmas Investing Heavily in Emerging Markets - BioJapan Conference
By 2030 the total pharma market size of BRIC countries, together with Mexico and Turkey, could reach $330 billion to $420 billion - almost equal to the combined market size of North America and Japan in 2006, which was $354 billion..
Japanese Pharmas Investing Heavily in Emerging Markets - BioJapan Conference
By 2030 the total pharma market size of BRIC countries, together with Mexico and Turkey, could reach $330 billion to $420 billion - almost equal to the combined market size of North America and Japan in 2006, which was $354 billion..
Japanese Pharmas Investing Heavily in Emerging Markets - BioJapan Conference
TOKYO - Major Japanese pharmaceutical companies are moving beyond their traditional comfort zones in a bid to evolve into global players, a Japanese pharma industry analyst said Oct. 8 at the BioJapan conference in Yokohama